Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Open accessThe DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Abstract
Inflammatory bowel diseases, which include Crohn’s disease and ulcerative colitis, affect several million individuals worldwide. Crohn’s disease and ulcerative colitis are complex diseases that are heterogeneous at the clinical, immunological, molecular, genetic, and microbial levels. Individual contributing factors have been the focus of extensive research. As part of the Integrative Human Microbiome Project (HMP2 or iHMP), we followed 132 subjects for one year each to generate integrated longitudinal molecular profiles of host and microbial activity during disease (up to 24 time points each; in total 2,965 stool, biopsy, and blood specimens). Here we present the results, which provide a comprehensive view of functional dysbiosis in the gut microbiome during inflammatory bowel disease activity. We demonstrate a characteristic increase in facultative anaerobes at the expense of obligate anaerobes, as well as molecular disruptions in microbial transcription (for example, among clostridia), metabolite pools (acylcarnitines, bile acids, and short-chain fatty acids), and levels of antibodies in host serum. Periods of disease activity were also marked by increases in temporal variability, with characteristic taxonomic, functional, and biochemical shifts. Finally, integrative analysis identified microbial, biochemical, and host factors central to this dysregulation. The study’s infrastructure resources, results, and data, which are available through the Inflammatory Bowel Disease Multi’omics Database ( http://ibdmdb.org ), provide the most comprehensive description to date of host and microbial activities in inflammatory bowel diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This relative absence of biomarkers for active UC may result both from its generally more benign phenotype (IBDMDB Investigators et al., 2019) and from the smaller number of active UC samples (n = 23) compared with active CD samples (n = 76); as a result, we focused our subsequent analyses on expression differences within the CD subcohort.”
From Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3 (2021) · cites this paper as IBDMDB Investigators et al., 2019
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This network of mechanistic associations identified several key components that are central to the alterations seen in IBD, highlighting octanoyl carnitine, several lipids and short-chain fatty acids, the taxa Faecalibacterium, Subdoligranulum, Roseburia, Alistipes, and Escherichia, some at both the metagenomic and metatranscriptomic levels, and host regulators of interleukins49.”
From The Integrative Human Microbiome Project (2019) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Multiple lines of evidence point towards central roles of gut microbiome perturbations in the pathogenesis of IBD.”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [152]
The cited source says what the claim attributes to it.
In the citing paper
“These studies, which have now reached the first stage of completion49–51, together provide a wealth of information and insights about not only microbial dynamics, but also associated human host responses and microbial inter-relationships.”
From The Integrative Human Microbiome Project (2019) · cites this paper as [49]
In the citing paper
“The authors could then use the 17 top taxa in their ranked list to identify which individuals are dysbiotic, an approach that demonstrated similar or better performance than the GMWI2 or another published metric called the “dysbiotic score”.195”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [195]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
Wickham, H. (2016) · Use R! · doi:10.1007/978-3-319-24277-4 · Cited by 33,115
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,826
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
Self-citationUPARSE: highly accurate OTU sequences from microbial amplicon reads
Edgar, R. C. (2013) · Nature Methods · doi:10.1038/nmeth.2604 · Cited by 16,707
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Fast and sensitive protein alignment using DIAMOND
Buchfink, B., Xie, C., & Huson, D. H. (2015) · Nature Methods · doi:10.1038/nmeth.3176 · Cited by 14,201
Cited by
Items 301–400 of 1,010
Iljazović, A., Amend, L., Gálvez, E. J. C., de Oliveira, R., & Strowig, T. (2021) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2021.151472 · Cited by 104
Lin, L., Lai, Z., Huisheng, Y., Zhang, J., Qi, W., Xie, F., & Mao, S. (2022) · The ISME Journal · doi:10.1038/s41396-022-01333-5 · Cited by 101
“Previous studies have shown that the accumulation of primary unconjugated BAs and BSH abundance are characteristic of colitis [57, 68], mainly due to the enrichment of opportunistic pathogens induced by CA administration [37].”
Bourgonje, A. R., Klóska, D., Grochot‐Przeczek, A., Feelisch, M., Cuadrado, A., & van Goor, H. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102603 · Cited by 104
Dynamics of the Stool Virome in Very Early-Onset Inflammatory Bowel Disease
Liang, G., Conrad, M. A., Kelsen, J. R., Kessler, L. R., Breton, J., Albenberg, L. G., Marakos, S., Galgano, A., Devas, N., Erlichman, J., et al. (2020) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjaa094 · Cited by 91
“Lastly, [5] the inability to assign phage sequences to bacterial hosts efficiently limits the interpretation of phage data.”
BackgroundVitale, M., Giacco, R., Laiola, M., Pepa, G. D., Luongo, D., Mangione, A., Salamone, D., Vitaglione, P., Ercolini, D., & Rivellese, A. A. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.05.025 · Cited by 103
Gut pathogen colonization precedes bloodstream infection in the neonatal intensive care unit
Schwartz, D. J., Shalon, N., Wardenburg, K. E., DeVeaux, A. L., Wallace, M. A., Hall-Moore, C. M., Ndao, I. M., Sullivan, J. E., Radmacher, P. G., ESCOBEDO, M. B., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg5562 · Cited by 96
Gut complement induced by the microbiota combats pathogens and spares commensals
Wu, M., Zheng, W., Song, X., Bao, B., Wang, Y., Ramanan, D., Yang, D., Liu, R., Macbeth, J. C., Do, E. A., et al. (2024) · Cell · doi:10.1016/j.cell.2023.12.036 · Cited by 99
Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
Stražar, M., Temba, G. S., Vlamakis, H., Kullaya, V. I., Lyamuya, F., Mmbaga, B. T., Joosten, L. A. B., van der Ven, A. J. A. M., Netea, M. G., de Mast, Q., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25213-2 · Cited by 91
Self-citationLi, B., Cheng, Z., Sun, X., Si, X., Gong, E. S., Wang, Y., Tian, J., Shu, C., Ma, F., Li, D., et al. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201901315 · Cited by 97
Xu, D., Ma, R.-J., Ju, Y., Song, X., Niu, B., Hong, W., Wang, R., Qin, Y., Zhao, Z., Zhang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32158-7 · Cited by 101
Toward a Standardized Strategy of Clinical Metabolomics for the Advancement of Precision Medicine
Long, N. P., Nghi, T. D., Kang, Y. P., Anh, N. H., Kim, H. M., Park, S. K., & Kwon, S. W. (2020) · Metabolites · doi:10.3390/metabo10020051 · Cited by 103
Precision medicine in inflammatory bowel disease: concept, progress and challenges
Borg-Bartolo, S. P., Boyapati, R. K., Satsangi, J., & Kalla, R. (2020) · F1000Research · doi:10.12688/f1000research.20928.1 · Cited by 90
Langdon, A. E., Schwartz, D. J., Bulow, C., Sun, X., Hink, T., Reske, K. A., Jones, C. R., Burnham, C. D., Dubberke, E. R., & Dantas, G. A. (2021) · Genome Medicine · doi:10.1186/s13073-021-00843-9 · Cited by 93
Heinken, A., Hertel, J., & Thiele, I. (2021) · npj Systems Biology and Applications · doi:10.1038/s41540-021-00178-6 · Cited by 103
“Reduced butyrate levels in IBD patients with dysbiosis have previously been attributed to reduced abundance of Roseburia and Faecalibacterium spp.(26,37).”
Interpretation of network-based integration from multi-omics longitudinal data
Bodein, A., Scott-Boyer, M.-P., Perin, O., Lê Cao, K.-A., & Droit, A. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1200 · Cited by 89
“These innovations have led to new biological insights and a better understanding of living organisms (5–7).”
BackgroundMethodLocation-specific signatures of Crohn’s disease at a multi-omics scale
Gonzalez, C. G., Mills, R. H., Zhu, Q., Sauceda, C., Knight, R. D., Dulai, P. S., & Gonzalez, D. J. (2022) · Microbiome · doi:10.1186/s40168-022-01331-x · Cited by 104
“This comports with prior findings in biopsies observing increased expression of host genes associated with neutrophil recruitment in CCD biopsies but not ICD [12].”
ResultSelf-citationMishima, Y., & Sartor, R. B. (2019) · Journal of Gastroenterology · doi:10.1007/s00535-019-01618-1 · Cited by 98
“Microbiota reciprocally interacts with each other and the diet to provide immunological signals to host and the same microbe sometimes behaves differently in different individuals [1, 11, 144].”
BackgroundInfluentialSpecific Eco-evolutionary Contexts in the Mouse Gut Reveal Escherichia coli Metabolic Versatility
Barroso-Batista, J., Pedro, M. F., Sales-Dias, J., Pinto, C., Thompson, J. A., Pereira, H., Demengeot, J., Gordo, I., & Xavier, K. B. (2020) · Current Biology · doi:10.1016/j.cub.2020.01.050 · Cited by 92
Metagenomics: a path to understanding the gut microbiome
Yen, S., & Johnson, J. S. (2021) · Mammalian Genome · doi:10.1007/s00335-021-09889-x · Cited by 104
Valdés-Mas, R., Leshem, A., Zheng, D., Cohen, Y., Kern, L., Zmora, N., He, Y., Katina, C., Eliyahu-Miller, S., Yosef-Hevroni, T., et al. (2025) · Cell · doi:10.1016/j.cell.2024.12.016 · Cited by 89
Liu, S., Rodriguez, J. S., Munteanu, V., Ronkowski, C., Sharma, N. K., Alser, M., Andreace, F., Blekhman, R., Błaszczyk, D., Chikhi, R., et al. (2025) · Nature Reviews Methods Primers · doi:10.1038/s43586-024-00376-6 · Cited by 112
“It shows improved clinical outcomes in diagnosing culture-negative sepsis and infections that are difficult to diagnose, such as pneumonia, severe diarrhoea and meningitis 247–250 .”
Alteration of the Gut Microbiome in Inflammatory Bowel Disease
Andoh, A., & Nishida, A. (2023) · Digestion · doi:10.1159/000525925 · Cited by 88
Yang, Y., Gharaibeh, R. Z., Newsome, R. C., & Jobin, C. (2020) · Nature Cancer · doi:10.1038/s43018-020-0078-7 · Cited by 98
Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome
Mishima, Y., & Ishihara, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228664 · Cited by 99
Mucus, commensals, and the immune system
Zhao, Q. S., & Maynard, C. L. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2041342 · Cited by 102
“gnavus) is also significantly increased in both CD and UC, sometimes transiently reaching a relative abundance of greater than 50% of patient fecal bacteria and dominated by strains capable of surviving the oxidative stressors characteristic of the inflamed gut.(43,104,105) Therefore, like AIEC,(106) the expansion of…”
BackgroundUnraveling the viral dark matter through viral metagenomics
Santiago-Rodríguez, T. M., & Hollister, E. B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1005107 · Cited by 107
Caetano, M. A. F., & Castelucci, P. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i28.9985 · Cited by 98
Microbiome epidemiology and association studies in human health
VanEvery, H., Franzosa, E. A., Nguyen, L. H., & Huttenhower, C. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00529-x · Cited by 94
Self-citationAkkermansia in the gastrointestinal tract as a modifier of human health
Panzetta, M. E., & Valdivia, R. H. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2406379 · Cited by 103
“108,109 Evidence indicates that the type of A. muciniphila subspecies present may differentially affect protection from CD and UC.”
BackgroundYang, J., Liang, J., Hu, N., He, N., Liu, B., Liu, G., & Qin, Y. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70091 · Cited by 120
“Serum amyloid A (SAA), a product of the inflammatory cascade in intestinal epithelial cells, serves as a prominent acute-phase reactant, with the gut microbiota potentially modulating neuroinflammation through the regulation of SAA levels [130, 131].”
BackgroundKaliannan, K., Li, X., Wang, B., Pan, Q., Chen, C., Hao, L., Xie, S., & Kang, J. X. (2019) · Communications Biology · doi:10.1038/s42003-019-0521-4 · Cited by 106
A framework for microbiome science in public health
Wilkinson, J. E., Franzosa, E. A., Everett, C., Li, C., trainees, H. R. A., Bae, S., Berzansky, I., Bhosle, A., Bjørnevik, K., Brennan, C. A., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01258-0 · Cited by 99
Self-citationThe functions of gut microbiota-mediated bile acid metabolism in intestinal immunity
He, Y., Shaoyong, W., Chen, Y., Li, M., Gan, Y., Sun, L., Liu, Y., Wang, Y., & Jin, M. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.05.015 · Cited by 124
“In addition to CA, PBAs such as TCA, GCA and GCDCA were notably higher in CD patients [208].”
InfluentialXia, B., Yang, M. G., Nguyen, L. H., He, Q., Zhen, J., Yu, Y., Di, M., Qin, X. S., Lu, K., Kuo, Z. C., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.08.005 · Cited by 94
Self-citationNarzo, A. D., Houten, S. M., Kosoy, R., Huang, R., Vaz, F. M., Hou, R., Wei, G., Wang, W., Comella, P., Dodatko, T., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.11.015 · Cited by 96
Metabolomics Insights into Inflammatory Bowel Disease: A Comprehensive Review
Aldars‐García, L., Gisbert, J. P., & Chaparro, M. (2021) · Pharmaceuticals · doi:10.3390/ph14111190 · Cited by 102
Piters, W. A. A. D. S., Watson, R. L., de Koff, E. M., Hasrat, R., Arp, K., Chu, M. L. J. N., de Groot, P. C. M., van Houten, M. A., Sanders, E. A. M., & Bogaert, D. (2022) · Nature Microbiology · doi:10.1038/s41564-021-01043-2 · Cited by 86
Kozik, A. J., Nakatsu, C. H., Chun, H., & Jones‐Hall, Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225079 · Cited by 89
“This was confirmed in a recent longitudinal multi-omic study of human IBD that produced evidence of distinct functional dysbiosis and microbial differences associated with IBD phenotype and activity[16].”
ResultThe human microbiome encodes resistance to the antidiabetic drug acarbose
Balaich, J. N., Estrella, M. A., Wu, G. G., Jeffrey, P. D., Biswas, A. G., Zhao, L., Korennykh, A. V., & Donia, M. S. (2021) · Nature · doi:10.1038/s41586-021-04091-0 · Cited by 90
Park, S.-Y., Rao, C., Coyte, K. Z., Kuziel, G. A., Zhang, Y., Huang, W., Franzosa, E. A., Weng, J., Huttenhower, C., & Rakoff-Nahoum, S. (2022) · Cell · doi:10.1016/j.cell.2022.01.002 · Cited by 92
Self-citationNiechcial, A., Schwarzfischer, M., Wawrzyniak, M., Atrott, K., Laimbacher, A., Morsy, Y., Katkeviciutė, E., Häfliger, J., Westermann, P., Akdiş, C. A., et al. (2023) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjad058 · Cited by 96
The Interplay between Androgen and Gut Microbiota: Is There a Microbiota-Gut-Testis Axis
Li, X., Cheng, W., Shang, H., Wei, H., & Deng, C. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00624-0 · Cited by 94
“Androgen level also affects the risk of inflammatory bowel disease (IBD), especially of ulcerative colitis Gender bias of diseases Androgen is involved in: Colorectal cancer Irritable bowel syndrome Ulcerative colitis Diabetes mellitus Sex dimorphism of gut microbiome Androgen is involved in the sex dimorphism of gut…”
BackgroundGut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives
Li, M., Yang, L., Mu, C., Sun, Y., Gu, Y., Chen, D., Liu, T., & Cao, H. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.03.038 · Cited by 100
“2019[8] Fecal samples LS-MS/MS Butyrate, Propionate, Valerate/isovalerate, Indole-3-propionat, Secondary bile acids”
BackgroundInfluentialBile acids-gut microbiota crosstalk contributes to the improvement of type 2 diabetes mellitus
Gao, R., Meng, X., Xue, Y., Mao, M., Liu, Y., Tian, X., Sui, B., Li, X., & Zhang, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1027212 · Cited by 92
“In inflammatory states, gut microbiota converts bile salts to BAs and SBAs inefficiently (Lloyd-Price et al., 2019).”
BackgroundPreterm birth is associated with xenobiotics and predicted by the vaginal metabolome
Kindschuh, W. F., Baldini, F., Liu, M. C., Gerson, K. D., Liao, J., Lee, H. H., Anton, L., Gajer, P., Ravel, J., Levy, M., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-022-01293-8 · Cited by 101
Immunology of bile acids regulated receptors
Fiorucci, S., Marchianò, S., Urbani, G., Giorgio, C. D., Distrutti, E., Zampella, A., & Biagioli, M. (2024) · Progress in Lipid Research · doi:10.1016/j.plipres.2024.101291 · Cited by 92
Personalised medicine in Crohn's disease
Noor, N. M., Verstockt, B., Parkes, M., & Lee, J. C. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30340-1 · Cited by 99
Dietary pectic substances enhance gut health by its polycomponent: A review
Wu, D., Ye, X., Linhardt, R. J., Liu, X., Zhu, K., Yu, C., Ding, T., Liu, D., He, Q., & Chen, S. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12723 · Cited by 83
Hygiene hypothesis and autoimmune diseases: A narrative review of clinical evidences and mechanisms
Murdaca, G., Greco, M., Borro, M., & Gangemi, S. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102845 · Cited by 100
Fungal microbiome in inflammatory bowel disease: a critical assessment
Underhill, D. M., & Braun, J. (2022) · Journal of Clinical Investigation · doi:10.1172/jci155786 · Cited by 99
“Looking ahead, adoption of bacterial metatranscriptomic (51, 52) and molecular replication (129) methods will provide metrics to better define fungal biologic activity in situ, but this will require a substantial scientific community effort to assemble comprehensive fungal metagenomic databases…”
Self-citationIntegrating multi-omics to unravel host-microbiome interactions in inflammatory bowel disease
Zhang, Y., Thomas, J. P., Korcsmáros, T., & Gul, L. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101738 · Cited by 104
Ho, G., Cartwright, J. A., Thompson, E. J., Bain, C. C., & Rossi, A. G. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa045 · Cited by 90
Mesnage, R., & Antoniou, M. N. (2020) · Current Research in Toxicology · doi:10.1016/j.crtox.2020.04.001 · Cited by 93
“Gut bacteria that are highly abundant can also be relatively transcriptionally inactive (Lloyd-Price et al., 2019) .”
BackgroundMethodInfluentialGut Microbiota: Its Potential Roles in Pancreatic Cancer
Li, Q., Jin, M., Liu, Y., & Jin, L. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.572492 · Cited by 99
“The Human Microbiome Project Part 2 has explored the mechanisms of GM in inflammatory bowel disease (Lloyd-Price et al., 2019), type 2 diabetes mellitus (T2DM) and prediabetes (Zhou et al.”
BackgroundMolecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases
Hyun, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179139 · Cited by 90
Walker, R. L., Vlamakis, H. C., Lee, J. W. J., Besse, L. A., Xanthakis, V., Vasan, R. S., Shaw, S. Y., & Xavier, R. J. (2021) · Genome Medicine · doi:10.1186/s13073-021-01007-5 · Cited by 92
“Stool samples were collected in 100% ethanol as previously described [7].”
MethodSelf-citationPaljetak, H. Č., Barešić, A., Panek, M., Perić, M., Matijašić, M., Lojkić, I., Barišić, A., Bender, D. V., Kelečić, D. L., Brinar, M., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2083419 · Cited by 94
“Adlercreutzia and Lactobacillus were also depleted in IBD.”
BackgroundInfluentialXiang, Y., Zhang, C., Wang, J., Cheng, Y., Wang, L., Tong, Y., & Yan, D. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04335-9 · Cited by 93
“However, most studies have focused only on the association between a limited number of genes and gut microbes or specific bacteria [9, 10].”
BackgroundGut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease
Pandey, H., Jain, D., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Intestinal Research · doi:10.5217/ir.2023.00080 · Cited by 100
“Various studies have confirmed reductions in the levels of medium-chain fatty acids and SCFAs, 119,189,191,192 dysregulation of bile acid metabolism, 113,193 and changes in the levels of amino acids 193,194 in the feces samples of IBD patients.”
BackgroundSchirmer, M., Stražar, M., Ávila-Pacheco, J., Rojas‐Tapias, D. F., Brown, E., Temple, E. R., Deik, A., Bullock, K. H., Jeanfavre, S., Pierce, K. A., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2023.12.013 · Cited by 94
Self-citationGut Microbiota Influence in Hematological Malignancies: From Genesis to Cure
Uribe‐Herranz, M., Klein-González, N., Rodríguez‐Lobato, L. G., Juan, M., & de Larrea, C. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031026 · Cited by 88
Touch, S., Godefroy, E., Rolhion, N., Danne, C., Oeuvray, C., Straube, M., Galbert, C., Brot, L., Alonso Salgueiro, I., Chadi, S., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.154722 · Cited by 80
Sui, H., Weil, A. A., Nuwagira, E., Qadri, F., Ryan, E. T., Mezzari, M. P., Phipatanakul, W., & Lai, P. S. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00953 · Cited by 93
Enteric Viruses and Inflammatory Bowel Disease
Tarris, G., de Rougemont, A., Charkaoui, M., Michiels, C., Martin, L., & Belliot, G. (2021) · Viruses · doi:10.3390/v13010104 · Cited by 89
Iyer, N. R., & Corr, S. C. (2021) · Nutrients · doi:10.3390/nu13124259 · Cited by 87
“In their study, dysbiosis was characterized by a loss of obligate anaerobes, an increase in facultative anaerobes and correlated with high variability in their multi-omic dataset [64].”
BackgroundMethodInfluentialNoecker, C. A., Eng, A., Muller, E., & Borenstein, E. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac003 · Cited by 90
Dietary manipulation of the gut microbiome in inflammatory bowel disease patients: Pilot study
Olendzki, B. C., Bucci, V., Cawley, C., Maserati, R., McManus, M. M., Olednzki, E., Madziar, C., Chiang, D., Ward, D. V., Pellish, R. S., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2046244 · Cited by 86
Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease
Hu, S., Bourgonje, A. R., Gaćeša, R., Jansen, B. H., Björk, J. R., Bangma, A., Hidding, I. J., van Dullemen, H. M., Visschedijk, M. C., Faber, K. N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45855-2 · Cited by 96
Manghi, P., Bhosle, A., Wang, K., Marconi, R., Selma‐Royo, M., Ricci, L., Asnicar, F., Golzato, D., Ma, W., Hang, D., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01858-9 · Cited by 90
Self-citationAndreu-Sánchez, S., Blanco-Míguez, A., Wang, D., Golzato, D., Manghi, P., Heidrich, V., Fackelmann, G., Zhernakova, D. V., Kurilshikov, A., Valles-Colomer, M., et al. (2025) · Cell · doi:10.1016/j.cell.2025.04.014 · Cited by 81
Yang, K., Deng, X., Jian, S., Zhang, M., Wen, C., Xin, Z., Zhang, L., Tong, A., Ye, S., Liao, P., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.813890 · Cited by 86
The Core Human Microbiome: Does It Exist and How Can We Find It? A Critical Review of the Concept
Sharon, I., Quijada, N. M., Pasolli, E., Fabbrini, M., Vitali, F., Agamennone, V., Dötsch, A., Selberherr, E., Grau, J. H., Meixner, M., et al. (2022) · Nutrients · doi:10.3390/nu14142872 · Cited by 96
“These include healthy Westerners from the US (HMP phases 1, 2, and 3) [9,37] and Denmark (MetaHIT), individuals with IBD from Spain (MetaHIT) [28], and a group of hunter-gatherers and traditional Bantu agriculturalists from the Central Africa Republic [38].”
BackgroundInfluentialApplications of human organoids in the personalized treatment for digestive diseases
Wang, Q., Guo, F., Jin, Y., & Ma, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01194-6 · Cited by 78
The gut microbiome-metabolome dataset collection: a curated resource for integrative meta-analysis
Muller, E., Algavi, Y. M., & Borenstein, E. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00345-5 · Cited by 99
Gut microbiota: A magical multifunctional target regulated by medicine food homology species
Zuo, W., Pang, Q., Yao, L.-P., Zhang, Y., Peng, C. Y., Huang, W., & Han, B. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.05.011 · Cited by 88
Inflammatory Bowel Disease–Associated Changes in the Gut: Focus on Kazan Patients
Sasso, G. L., Khachatryan, L., Kondylis, A., Battey, J. N. D., Sierro, N., Danilova, N. A., Grigoryeva, T. V., Markelova, M., Khusnutdinova, D. R., Laikov, A. V., et al. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa188 · Cited by 85
Chen, H., Wu, X., Xu, C., Lin, J., & Liu, Z. (2021) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbab025 · Cited by 83
Guidelines for Transparency on Gut Microbiome Studies in Essential and Experimental Hypertension
Marques, F. Z., Jama, H. A., Tsyganov, K., Gill, P. A., Rhys-Jones, D. R., Muralitharan, R. R., Muir, J. G., Holmes, A. J., & Mackay, C. R. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13079 · Cited by 84
“Another option is to sample the same participants several times over time, such as recently done for inflammatory bowel diseases.(67) Assessing within-individual variance will give far greater resolution.”
BackgroundLee, K. S., Pereira, F. C., Palatinszky, M., Behrendt, L., Alcolombri, U., Berry, D., Wagner, M., & Stocker, R. (2020) · Nature Protocols · doi:10.1038/s41596-020-00427-8 · Cited by 78
The human lung microbiome—A hidden link between microbes and human health and diseases
Yi, X., Gao, J., & Wang, Z. (2022) · iMeta · doi:10.1002/imt2.33 · Cited by 80
“While multiomics are increasingly being applied to gut microbiome studies [32, 33], its implementation in the lung microbiome remains sparse.”
BackgroundRodríguez-Daza, M.-C., & de Vos, W. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010045 · Cited by 96
Jiang, L., Ye, Y., Han, Y., Wang, Q., Lu, H., Li, J., Qian, W., Zeng, X. Y., Zhang, Z., Zhao, Y., et al. (2024) · Cell Discovery · doi:10.1038/s41421-024-00665-0 · Cited by 94
Jia, M., Zhu, S., Xue, M., Chen, H., Xu, J., Song, M., Tang, Y., Liu, X., Tao, Y., Zhang, T., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01723-9 · Cited by 96
The potential role of B5: A stitch in time and switch in cytokine
Gheita, A., Gheita, T. A., & Kenawy, S. A. (2019) · Phytotherapy Research · doi:10.1002/ptr.6537 · Cited by 80
Hanson, B. T., Kits, K. D., Löffler, J., Burrichter, A. G., Fiedler, A. W., Denger, K., Frommeyer, B., Herbold, C. W., Rattei, T., Karcher, N., et al. (2021) · The ISME Journal · doi:10.1038/s41396-021-00968-0 · Cited by 76
Mycobiome and Cancer: What Is the Evidence?
Vallianou, N. G., Kounatidis, D. C., Christodoulatos, G. S., Panagopoulos, F., Karampela, Ι., & Dalamaga, Μ. (2021) · Cancers · doi:10.3390/cancers13133149 · Cited by 81
“Overall, mycobiota dysbiosis is suggested to be a triggering factor of CRC among subjects with IBD through chronic inflammation and secretion of toxic metabolites, which may cause DNA damage.”
BackgroundInfluentialZuo, W., Wang, B., Bai, X., Luan, Y., Fan, Y., Michail, S. K., & Sun, F. (2022) · Scientific Reports · doi:10.1038/s41598-022-07995-7 · Cited by 88
Ma, S., Zhang, J., Liu, H., Li, S., & Wang, Q. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.896591 · Cited by 85
“IBD pathogenesis through evading the immune system of the host, linking to intestinal epithelial cells, and promoting excessive inflammation (Lloyd-Price et al., 2019).”
BackgroundVujkovic-Cvijin, I., Welles, H. C., Ha, C. W. Y., Huq, L., Mistry, S., Brenchley, J. M., Trinchieri, G., Devkota, S., & Belkaid, Y. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl3927 · Cited by 91
Integrative multi-omics approaches to explore immune cell functions: Challenges and opportunities
Wang, X., Dian, F., Yang, Y., Gimple, R. C., & Zhou, S. (2023) · iScience · doi:10.1016/j.isci.2023.106359 · Cited by 96
Xu, D., Wu, Q.-Y., Liu, W., Hu, G., Meng, H., & Wang, J. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125919 · Cited by 79
Kumar, M., Garand, M., & Al Khodor, S. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-02174-1 · Cited by 75
Tomofuji, Y., Maeda, Y., Oguro-Igashira, E., Kishikawa, T., Yamamoto, K., Sonehara, K., Motooka, D., Matsumoto, Y., Matsuoka, H., Yoshimura, M., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220687 · Cited by 83
Metatranscriptomics-guided genome-scale metabolic modeling of microbial communities
Zampieri, G., Campanaro, S., Angione, C., & Treu, L. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100383 · Cited by 94
“(C) Relationship between the sum of individual microbes’ export rate of butyrate a correlations are found for all model types, CoCo-GEMs and METRADE return a selected cohort consists of a group of five patients diagnosed with Crohn’s disease (CD) displaying an altered microbiota and five control subjects.(37) Such a m…”
BackgroundNovel approaches in IBD therapy: targeting the gut microbiota-bile acid axis
Pan, Y., Zhang, H., Li, M., He, T., Guo, S., Zhu, L., Tan, J., & Wang, B. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2356284 · Cited by 89
“…indicating a depletion of SBA-producing bacteria like Firmicutes , Clostridium IV and XIVa, Butyricicoccus , Clostridium , Faecalibacterium , Ruminococcaceae , and Roseburia , 114–116 which are known to possess BSH and HSDHs enzymes responsible for the deconjugation and biotransformation of BAs.”
BackgroundInfluentialGarcía-Bayona, L., Coyne, M. J., & Comstock, L. E. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009541 · Cited by 78
A statistical model for describing and simulating microbial community profiles
Ma, S., Ren, B., Mallick, H., Moon, Y. S., Schwager, E., Maharjan, S., Tickle, T. L., Lu, Y., Carmody, R. N., Franzosa, E. A., et al. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008913 · Cited by 88
Self-citationChandra, H., Sharma, K. K., Tuovinen, O. H., Sun, X., & Shukla, P. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1979882 · Cited by 87
Research progress on the relationship between intestinal microecology and intestinal bowel disease
Fu, Q.-H., Song, T., Ma, X., & Cui, J. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12262 · Cited by 84
Lu, L., Dong, J., Liu, Y., Qian, Y., Zhang, G., Zhou, W., Zhao, A., Ji, G., & Xu, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.964793 · Cited by 76
“Currently, representative sets of multiomics studies (Lloyd-Price et al., 2019; Mars et al., 2020) are available for the in-depth analysis of the gut microbiota to understand the molecular mechanisms by which it affects tumorigenesis and tumour progression.”
Background
Metadata
- Authors
- Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., Andrews, E., Ajami, N. J., Bonham, K. S., Brislawn, C. J., Casero, D., Courtney, H., Gonzalez, A., Graeber, T. G., Hall, A. B., Lake, K., Landers, C. J., Mallick, H., Plichta, D. R., Prasad, M., Rahnavard, G., Sauk, J., Shungin, D., Vázquez-Baeza, Y., White, R. A., IBDMDB Investigators, Bishai, J., Bullock, K., Deik, A., Dennis, C., Kaplan, J. L., Khalili, H., McIver, L. J., Moran, C. J., Nguyen, L., Pierce, K. A., Schwager, R., Sirota-Madi, A., Stevens, B. W., Tan, W., ten Hoeve, J. J., Weingart, G., Wilson, R. G., Yajnik, V., Braun, J., Denson, L. A., Jansson, J. K., Knight, R., Kugathasan, S., McGovern, D. P. B., Petrosino, J. F., Stappenbeck, T. S., Winter, H. S., Clish, C. B., Franzosa, E. A., Vlamakis, H., Xavier, R. J., & Huttenhower, C.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Broad Institute (US)
- Baylor College of Medicine (US)
- Pacific Northwest National Laboratory (US)
- University of California, Los Angeles (US)
- Cincinnati Children's Hospital Medical Center (US)
- Cedars-Sinai Medical Center (US)
- Emory University (US)
- University of California San Diego (US)
- Washington University in St. Louis (US)
- Corresponding author
- Huttenhower, Curtis
- ORCID
- Arze, Cesar
- Ananthakrishnan, Ashwin N.
- Schirmer, Melanie
- Ajami, Nadim J.
- Bonham, Kevin S.
- Brislawn, Colin J.
- Casero, David
- Graeber, Thomas G.
- Hall, A. Brantley
- Mallick, Himel
- Plichta, Damian R.
- Sauk, Jenny
- Shungin, Dmitry
- Bullock, Kevin
- Deik, Amy
- Khalili, Hamed
- McIver, Lauren J.
- Nguyen, Long
- Pierce, Kerry A.
- Yajnik, Vijay
- Knight, Rob
- McGovern, Dermot P. B.
- Winter, Harland S.
- Clish, Clary B.
- Franzosa, Eric A.
- Vlamakis, Hera
- Xavier, Ramnik J.
- Huttenhower, Curtis
- Venue
- Nature
- Published
- 2019-05-29
- Volume
- 569
- Issue
- 7758
- Pages
- 655-662
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6650278
- OpenAlex
- W2947189704
- Cited by
- 3,143
- References
- 101
- Citations by year
- 2026: 500 · 2025: 555 · 2024: 498 · 2023: 402 · 2022: 441 · 2021: 452 · 2020: 247 · 2019: 42
- FWCI
- 98.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- National Science Foundation (1053486, DEAC05–76RL01830, 76RL01830)
- U.S. Department of Energy (DE-AC05–76RL01830, 76RL01830, AC05-76RL01830, DE-AC05?)
- Battelle (AC05-76RL01830, DE- AC05-76RL01830, DE-AC05)
- Leona M. and Harry B. Helmsley Charitable Trust (P01DK046763, U01DK062413)
- Harvard T.H. Chan School of Public Health
- Crohn's and Colitis Foundation (563526)
- Broad Institute
- Vetenskapsrådet (4.1-2016-00416)
- National Institutes of Health (DBI-1053486, UL1TR001881, DE-AC05-76RL01830)
- National Human Genome Research Institute (R01HG005969)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK046763, R24DK110499, U54DK102557, U01DK062413, P30DK078392, P30DK043351, P30DK040561)
- National Institute of Dental and Craniofacial Research (U54DE023798)
- National Center for Advancing Translational Sciences
- Army Research Office (W911NF-11-1-0473, W911NF, W911NF-11)
- Pacific Northwest National Laboratory (DEAC0576RL01830, 76RL01830)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- inflammatory bowel disease, Crohn's disease, ulcerative colitis, gut microbiota, dysbiosis, multi-omics, facultative anaerobes, obligate anaerobes, Clostridia, acylcarnitines, bile acids, short-chain fatty acids, serum antibodies, disease activity, temporal variation, host-microbe interactions
- MeSH terms
- Gastrointestinal Microbiome, Animals, Fungi, Health, Humans, Phylogeny, Species Specificity, Viruses, Inflammatory Bowel Diseases, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.